Trial intelligence / Profile preview

Verification Study of Fentanyl Patch in Osteoarthritis or Low Back Pain

NCT01008618Phase 3Completed

Sponsor
Janssen Pharmaceutical
Start
Jan 2009
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of fentanyl (transdermal patch + oral transmucosal lozenge) in osteoarthritis (OA), low back pain (LBP), sponsored by Janssen Pharmaceutical. Started Jan 2009; status: completed.

02

Drugs

fentanyl (transdermal patch + oral transmucosal lozenge)
03

Conditions

osteoarthritis (OA)low back pain (LBP)

Beyond the preview

Go deeper on NCT01008618.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01008618.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call